Mixtard is a suspension for injection that contains the active substance human insulin. It is available as vials, cartridges (Penfill) or pre-filled pens (InnoLet or FlexPen). Mixtard contains both fast-acting (soluble) and long-acting (isophane) insulin: Mixtard 50: soluble insulin 50% and isophane insulin 50%. What is Mixtard used for?

2025年2月11日 · Human Mixtard 70/30 Suspension for Injection 100IU/ml is a combination of two medicines, an intermediate-acting and a short-acting type of insulin. It is used in the treatment of diabetes mellitus (type 1 and 2) to improve blood sugar control both in adults and children.

Mixtard is a suspension for injection that contains the active substance human insulin. It is available as vials, cartridges (Penfill) or pre-filled pens (InnoLet or FlexPen). Mixtard contains both fast-acting (soluble) and long-acting (isophane) insulin:

What is Mixtard? Mixtard is a range of insulin suspensions for injection. Mixtard is supplied in vials, cartridges (PenFill) or pre-filled pens (NovoLet, FlexPen or InnoLet). Mixtard contains the active substance insulin human (rDNA). Mixtard contains both fast-acting (soluble) and long-acting (isophane) insulin:

Mixtard is a suspension for injection that contains the active substance human insulin. It is available as vials, cartridges (Penfill) or pre-filled pens (InnoLet or FlexPen). Mixtard contains both fast-acting (soluble) and long-acting (isophane) insulin: • Mixtard 50: soluble insulin 50% and isophane insulin 50%. What is Mixtard used for?

Treatment of diabetes mellitus.

Mixtard是一種雙效作用的胰島素,包含速效與長效 ... Mixtard通常於大腿或腹壁皮下注射。 下列物質可能會減少病人的胰島素需求量

1. What Mixtard® is used for Mixtard® is human insulin used to treat diabetes. Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of your blood sugar. 2. How Mixtard® works Mixtard® is a mixture of fast-acting insulin and long-acting insulin. This means that it will start to lower your

2023年7月1日 · Mixtard 50/50 is an intermediate acting insulin preparation. Its hypoglycaemic effect after subcutaneous administration begins after approximately 0.5 hour, is maximal between 4 and 8 hours and terminates after approximately 24 hours. Mixtard 50/50 is not exactly equivalent to its component insulins. Clinical trials.

Mixtard® 30 and Protaphane® are human insulins used to treat diabetes. Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of your blood sugar. Mixtard® 30 is a mixture of fast-acting insulin and long-acting insulin.